As one of the great popular actors of our time, Harrison Ford, is much admired by filmgoers in Taiwan and overseas. However, in a Ford-produced movie that sees him playing the role of a Midwestern medical researcher looking for a cure for a rare muscle disease, released earlier this year in theaters in the US and now worldwide on DVD, titled Extraordinary Measures, Ford neglected to give credit to the actual scientist who found the cure for Pompe Disease — Chen Yuan-tsong (陳垣崇) of Taiwan.
Chen did the original research that led to finding the cure in the 1990s while he was at Duke University in North Carolina. A writer for the Wall Street Journal, Geeta Annand, wrote a series of newspaper articles about the search for the cure and later turned her stories into a book titled The Cure.
Ford bought the film rights to the book, asked his scriptwriters to turn Chen into a white lab scientist named Dr Stonehill and completely left any mention of Chen’s work out of the picture. Not one part of the movie’s dialog mentions Chen’s name at all and even the opening and closing credits fail to mention the doctor’s name.
Ford and the Hollywood studio that bankrolled the movie need to explain themselves. Sure, movies are movies and Hollywood is Hollywood, but to take the real-life medical work of a Taiwanese scientist and turn it into a Hollywood medical thriller “inspired by true events” that does even mention the name of the man who inspired the movie is an affront to medical researchers everywhere.
When Chen recently attended a press conference on the sidelines of the release of the DVD version of the movie, the Central News Agency (CNA) in Taipei reported that he had “mixed feelings” about the movie.
When this reporter recently asked Chen to explain his feelings about the movie, he told me: “What the movie failed to show was who actually developed the drug that the characters Megan and Patrick in the film eventually received. There were many scientists behind the scenes that helped to find the cure.”
However, Chen was gracious in his remarks, adding: “However, I still appreciate Harrison Ford bringing the Pompe story to movie audiences worldwide. This kind of Hollywoodized medical drama helps create public awareness of rare devastating diseases such as Pompe, and hopefully the film will create support channels for helping those children who suffer from Pompe and their families.”
Despite Hollywood’s neglect, Chen is now being recognized in Taiwan for his medical research on Pompe Disease.
“Regardless of how Hollywood decided to recast Chen, his contribution to helping find the cure is well established,” CNA said. “He developed the treatment with colleagues at Duke University Medical Center. His R&D was mostly done in the United States, but Chen conducted his clinical trials for the cure — later named Myozyme — in Taiwan, at National Taiwan University Hospital.”
“Myozyme, which took Chen and his team 15 years to research and develop, was introduced in Taiwan by US pharmaceutical company Genzyme and included as a drug covered by Taiwan’s National Health Insurance program in 2005. Myozyme was sold in Europe and the United States after it was approved by the US government and the European Union health authority in 2006,” CNA said.
Chen’s work has resulted in saving over a thousand lives of those with Pompe Disease worldwide — also known as “acid maltase deficiency” — including 34 children in Taiwan, the CNA said.
However, not one bit of dialogue in the movie or one small note of thanks in the film’s opening or closing credits mention Chen’s name at all. He has been airbrushed out of the story, whitewashed out of the way by Hollywood moguls. Not a pretty picture.
And yet the movie itself, as Chen so graciously said, is a good one and an important one. I saw the movie the other day on a rented DVD and I agree with Chen — the film serves an important purpose in educating the public, and Ford plays his role well.
Dan Bloom is a US writer based in Taiwan.
On May 7, 1971, Henry Kissinger planned his first, ultra-secret mission to China and pondered whether it would be better to meet his Chinese interlocutors “in Pakistan where the Pakistanis would tape the meeting — or in China where the Chinese would do the taping.” After a flicker of thought, he decided to have the Chinese do all the tape recording, translating and transcribing. Fortuitously, historians have several thousand pages of verbatim texts of Dr. Kissinger’s negotiations with his Chinese counterparts. Paradoxically, behind the scenes, Chinese stenographers prepared verbatim English language typescripts faster than they could translate and type them
More than 30 years ago when I immigrated to the US, applied for citizenship and took the 100-question civics test, the one part of the naturalization process that left the deepest impression on me was one question on the N-400 form, which asked: “Have you ever been a member of, involved in or in any way associated with any communist or totalitarian party anywhere in the world?” Answering “yes” could lead to the rejection of your application. Some people might try their luck and lie, but if exposed, the consequences could be much worse — a person could be fined,
Xiaomi Corp founder Lei Jun (雷軍) on May 22 made a high-profile announcement, giving online viewers a sneak peek at the company’s first 3-nanometer mobile processor — the Xring O1 chip — and saying it is a breakthrough in China’s chip design history. Although Xiaomi might be capable of designing chips, it lacks the ability to manufacture them. No matter how beautifully planned the blueprints are, if they cannot be mass-produced, they are nothing more than drawings on paper. The truth is that China’s chipmaking efforts are still heavily reliant on the free world — particularly on Taiwan Semiconductor Manufacturing
On May 13, the Legislative Yuan passed an amendment to Article 6 of the Nuclear Reactor Facilities Regulation Act (核子反應器設施管制法) that would extend the life of nuclear reactors from 40 to 60 years, thereby providing a legal basis for the extension or reactivation of nuclear power plants. On May 20, Chinese Nationalist Party (KMT) and Taiwan People’s Party (TPP) legislators used their numerical advantage to pass the TPP caucus’ proposal for a public referendum that would determine whether the Ma-anshan Nuclear Power Plant should resume operations, provided it is deemed safe by the authorities. The Central Election Commission (CEC) has
RSS